Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Magnus Fovaeus"'
Publikováno v:
BJUI Compass, Vol 3, Iss 5, Pp 363-370 (2022)
Abstract Objectives We aim to determine if robot‐assisted retroperitoneal lymph node dissection (R‐RPLND) can be performed as a safe option to open RPLND in selected patients with metastatic germ cell cancer. Patients and methods This population
Externí odkaz:
https://doaj.org/article/85637390191d4f67b49982c3f4ada87c
Publikováno v:
BJUI compass. 3(5)
We aim to determine if robot-assisted retroperitoneal lymph node dissection (R-RPLND) can be performed as a safe option to open RPLND in selected patients with metastatic germ cell cancer.This population-based prospective study was performed at a one
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e600a69bb2043a1190f80bcac19df7e1
https://pubmed.ncbi.nlm.nih.gov/35950045
https://pubmed.ncbi.nlm.nih.gov/35950045
Autor:
Eirikur Gudmundsson, Frode Nilsen, Harry Nisen, Petrus Järvinen, Pernilla Sundqvist, Peter E. Clark, Bjarne Kromann-Andersen, Lars Lund, Christian Beisland, Magnus Fovaeus, Börje Ljungberg
Publikováno v:
Research and Reports in Urology
Lund, L, Nisen, H, Järvinen, P, Fovaeus, M, Gudmundsson, E, Kromann-Andersen, B, Ljungberg, B, Nilsen, F, Sundqvist, P, Clark, P E & Beisland, C 2018, ' Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors : A questionnaire survey in the nordic countries (the NORENCA-2 study) ', Research and Reports in Urology, vol. 10, pp. 181-187 . https://doi.org/10.2147/RRU.S177774
Lund, L, Nisen, H, Järvinen, P, Fovaeus, M, Gudmundsson, E, Kromann-Andersen, B, Ljungberg, B, Nilsen, F, Sundqvist, P, Clark, P E & Beisland, C 2018, ' Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors : A questionnaire survey in the nordic countries (the NORENCA-2 study) ', Research and Reports in Urology, vol. 10, pp. 181-187 . https://doi.org/10.2147/RRU.S177774
Lars Lund,1,2 Harry Nisen,3 Petrus Järvinen,3 Magnus Fovaeus,4 Eirikur Gudmundsson,5 Bjarne Kromann-Andersen,6 Börje Ljungberg,7 Frode Nilsen,8 Pernilla Sundqvist,9 Peter E Clark,10 Christian Beisland11,12 1Department of Urology, Odense University
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23b5ed5ec16a6a91c9b031c4098b47a2
https://www.dovepress.com/use-of-venous-thrombotic-embolic-prophylaxis-in-patients-undergoing-su-peer-reviewed-article-RRU
https://www.dovepress.com/use-of-venous-thrombotic-embolic-prophylaxis-in-patients-undergoing-su-peer-reviewed-article-RRU
Autor:
Pernilla Sundqvist, Harry Nisen, Bjarne Kromann-Andersen, Petrus Järvinen, Frode Nilsen, Lars Lund, Eirikur Guðmundsson, Christian Beisland, Magnus Fovaeus, Börje Ljungberg
Publikováno v:
Nisen, H, Järvinen, P, Fovaeus, M, Guðmundsson, E, Kromann-Andersen, B, Ljungberg, B, Lund, L, Nilsen, F, Sundqvist, P & Beisland, C 2017, ' Contemporary treatment of renal tumors : a questionnaire survey in the Nordic countries (the NORENCA-I study) ', Scandinavian Journal of Urology and Nephrology, vol. 51, no. 5, pp. 360-366 . https://doi.org/10.1080/21681805.2017.1326524
Objective: The five Nordic countries comprise 25 million people, and have similar treatment traditions and healthcare systems. To take advantage of these similarities, a collaborative group (Nordic Renal Cancer Group, NORENCA) was founded in 2015. Ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07841fc71d6166eca81ceeb0689fb589
https://pubmed.ncbi.nlm.nih.gov/28644697
https://pubmed.ncbi.nlm.nih.gov/28644697
Autor:
Harry Nisen, Bjarne Kromann-Andersen, Christian Beisland, Pernilla Sundqvist, Frode Nilsen, Lars Lund, Magnus Fovaeus, Börje Ljungberg, Eirikur Gudmundsson, Petrus Järvinen
Publikováno v:
European Urology Supplements. 16:e1585-e1586
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72693885cbb88b4bf8aba9b478f7869a
https://doi.org/10.1016/s1569-9056(17)30961-2
https://doi.org/10.1016/s1569-9056(17)30961-2
Publikováno v:
Journal of Urology. 137
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::659a849be9023691692f76682e2bd46d
https://doi.org/10.1016/s0022-5347(17)75970-8
https://doi.org/10.1016/s0022-5347(17)75970-8
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e1b9626756d85ac5e84ff2e320513682
http://www.scopus.com/inward/record.url?eid=2-s2.0-0024204646&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0024204646&partnerID=MN8TOARS
Autor:
Lars Lund, Harry Nisen, Petrus Järvinen, Magnus Fovaeus, Eirikur Gudmundsson, Bjarne Kromann-Andersen, Börje Ljungberg, Frode Nilsen, Pernilla Sundqvist, Peter Clark, Christian Beisland
Publikováno v:
University of Southern Denmark
Lund, L, Nisen, H, Järvinen, P, Fovaeus, M, Gudmundsson, E, Kromann-Andersen, B, Ljungberg, B, Nilsen, F, Sundqvist, P, Clark, P & Beisland, C 2017, ' Use of venous-thrombotic-embolic (vte) prophylaxis in patients undergoing surgery for renal tumors in nordic countries (the norenca-ii study) ', 31th Biennial Conference of the Scandinavian Assiciation of Urology, Odense, Denmark, 14/06/2017-16/06/2017 .
Lund, L, Nisen, H, Järvinen, P, Fovaeus, M, Gudmundsson, E, Kromann-Andersen, B, Ljungberg, B, Nilsen, F, Sundqvist, P, Clark, P & Beisland, C 2017, ' Use of venous-thrombotic-embolic (vte) prophylaxis in patients undergoing surgery for renal tumors in nordic countries (the norenca-ii study) ', 31th Biennial Conference of the Scandinavian Assiciation of Urology, Odense, Denmark, 14/06/2017-16/06/2017 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::944c4812efa38fd768e855fc8db5eda7
https://portal.findresearcher.sdu.dk/en/publications/69c4a709-c9d2-41e7-ac29-d699ec433e4c
https://portal.findresearcher.sdu.dk/en/publications/69c4a709-c9d2-41e7-ac29-d699ec433e4c